Daniel Erskine

Has grant

Newcastle University

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Neuroscience Neuroscience professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Open

Lipids, lysosomes and mitochondria: towards a unified understanding of Lewy body dementia

Open Date: 2023-01-01

Close Date: 2027-01-01

Grant: Close

Are Lewy bodies really the enemy in Lewy body dementia?

Open Date: 2019-04-01

Close Date: 2021-04-01

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

David Koss

Newcastle University

UNITED KINGDOM

View details

Gavin Hudson

Senior Lecturer

Newcastle University

UNITED KINGDOM

View details

Yi Shiau Ng

Clinical Senior Lecturer & Honorary Consultant Neurologist

Newcastle University

UNITED KINGDOM

View details

Amy E. Vincent

Newcastle University

UNITED KINGDOM

View details

Wilma van de Berg

Associate professor

Amsterdam UMC

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Daniel Erskine

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (11)

Astrocytic pathology in Alpers’ syndrome

Neurological Phenotypes in Mouse Models of Mitochondrial Disease and Relevance to Human Neuropathology

Parkinson’s disease neurons exhibit alterations in mitochondrial quality control proteins

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage

Novel engineered nanobodies specific for N‐terminal region of alpha‐synuclein recognize Lewy‐body pathology and inhibit in‐vitro seeded aggregation and toxicity

Delineating selective vulnerability of inhibitory interneurons in Alpers' syndrome.

α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.

Inflammation in dementia with Lewy bodies.

Blood mRNA Expression in Alzheimer's Disease and Dementia With Lewy Bodies

alpha-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity

Collaborators (5)

David Koss

Gavin Hudson

Yi Shiau Ng

Amy E. Vincent

Wilma van de Berg

Make your next move.